The Precision Peptide Company Inc. (CSE:BPC)

CSE:BPC Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	0.41	0.96	0.14	0.05	0.08	0.81
Cash & Short-Term Investments	0.41	0.96	0.14	0.05	0.08	0.81
Cash Growth	95.88%	585.26%	171.27%	-32.00%	-90.59%	-
Accounts Receivable	0.07	0.01	0	0.04	0.09	0.07
Other Receivables	-	0.07	0.02	0.01	0.04	0.02
Receivables	0.07	0.07	0.02	0.05	0.13	0.08
Inventory	0.06	0.07	-	0.06	0.09	0.01
Prepaid Expenses	0.1	0.23	0.02	0.02	0.18	0.38
Total Current Assets	0.65	1.33	0.18	0.18	0.47	1.28
Property, Plant & Equipment	-	-	-	0.02	0.02	0.02
Other Intangible Assets	-	-	-	-	0.01	0.04
Total Assets	0.65	1.33	0.18	0.19	0.5	1.34
Accounts Payable	0.38	0.35	0.49	0.24	0.13	0.03
Accrued Expenses	-	0.05	0.22	0.09	0.16	0.09
Short-Term Debt	-	-	0.02	-	-	-
Total Current Liabilities	0.38	0.4	0.73	0.33	0.28	0.12
Total Liabilities	0.38	0.4	0.73	0.33	0.28	0.12
Common Stock	8.31	8.29	2.46	1.8	0.8	0.75
Retained Earnings	-9.92	-8.52	-3.99	-2.96	-1.3	-0.17
Comprehensive Income & Other	1.87	1.15	0.98	1.02	0.72	0.65
Shareholders' Equity	0.27	0.93	-0.55	-0.14	0.22	1.23
Total Liabilities & Equity	0.65	1.33	0.18	0.19	0.5	1.34
Total Debt	-	-	0.02	-	-	-
Net Cash (Debt)	0.41	0.96	0.12	0.05	0.08	0.81
Net Cash Growth	117.76%	685.18%	136.75%	-32.00%	-90.59%	-
Net Cash Per Share	0.01	0.04	0.02	0.01	0.02	1.22
Filing Date Shares Outstanding	40.48	40.52	7.71	6.58	6	4.56
Total Common Shares Outstanding	40.48	40.44	7.71	6.16	4.61	4.53
Working Capital	0.27	0.93	-0.55	-0.15	0.19	1.17
Book Value Per Share	0.01	0.02	-0.07	-0.02	0.05	0.27
Tangible Book Value	0.27	0.93	-0.55	-0.14	0.21	1.19
Tangible Book Value Per Share	0.01	0.02	-0.07	-0.02	0.05	0.26
Machinery	-	-	-	0.02	0.02	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.